See the DrugPatentWatch profile for Dayvigo
What’s the difference between Dayvigo (lemborexant) and zopiclone?
Dayvigo is a sedative sleep medicine in the orexin receptor antagonist class. It works by blocking orexin signaling, which helps drive wakefulness, to promote sleep.
Zopiclone is a non-benzodiazepine hypnotic (a “Z-drug”) that works on the GABA-A receptor system to reduce brain activity and induce sleep.
Because they work through different mechanisms, they can differ in how they affect sleep timing, maintenance, and next-day alertness, even though both are used for insomnia.
How are they typically used for insomnia?
Both drugs are prescribed for short-term treatment of insomnia, but they are often chosen based on the pattern of sleep problems and patient factors (for example, whether difficulty is falling asleep, staying asleep, or both). Clinicians also consider the risks of sedation, falls, and next-day impairment.
(Exact indications and dosing rules depend on country labeling and the specific product.)
Which one tends to help with sleep onset vs sleep maintenance?
Dayvigo’s orexin-blocking mechanism is often used when prescribers want help with sleep initiation and/or sleep maintenance, depending on the dosing strategy and the patient’s sleep pattern.
Zopiclone is commonly used to help patients fall asleep faster, with effects that can vary in how well they improve nighttime sleep continuity.
If you tell me whether the main issue is trouble falling asleep or waking during the night, I can help map which option is more commonly considered for that pattern.
What about next-day drowsiness and driving risk?
Both medications can cause sedation and impair reaction time. Patients are usually advised not to drive or operate machinery the morning after taking them until they know how they affect them.
The practical difference is that individual tolerance varies, and dose, age, liver function, and other sedating medications strongly influence next-day effects for both drugs.
What are the main side effects patients ask about?
For both Dayvigo and zopiclone, common concerns include:
- Excess sleepiness or sedation
- Dizziness
- Headache
- Nausea (more variable by agent)
- Cognitive effects such as confusion (risk increases with dose, age, and drug interactions)
A key class-wide safety issue with “hypnotics” is abnormal behaviors during sleep (like sleepwalking or doing activities while not fully awake). That risk is generally something prescribers screen for, especially in people who have a history of parasomnias.
Are there dangerous interactions with alcohol or other sedatives?
Yes. Mixing either medication with alcohol or other central nervous system depressants (for example, opioids or certain anxiety medications) increases the risk of dangerous sedation, breathing suppression, and impaired coordination. Prescribers typically avoid or strictly limit such combinations.
Can they be taken together?
Generally, no. Combining hypnotic sedatives is usually avoided because it increases sedation and impairment risks without clear added benefit. If a patient is already taking one insomnia medicine, the next step is usually to reassess the regimen rather than add another sedative.
How long are they prescribed for?
Insomnia treatments are often limited to the shortest duration needed, with reassessment if symptoms persist. Longer-term use can increase risks related to dependence, tolerance, falls, and ongoing impairment (risk profile differs by class, but clinicians still monitor closely).
Which has dependence/tolerance concerns?
Zopiclone (a Z-drug) has a higher association with tolerance and dependence risk compared with many non-benzodiazepine approaches, and stopping suddenly can be problematic for some patients.
Dayvigo’s risk profile is different because it is not a GABA-A hypnotic, but it still requires careful prescribing and follow-up.
What if someone wants to switch from zopiclone to Dayvigo?
Switching depends on dose, how often the patient uses zopiclone, and the reason for switching (insufficient sleep, side effects, next-day impairment, or risk concerns). In many cases clinicians taper or adjust timing to reduce rebound insomnia or withdrawal-type symptoms where relevant.
If you share your current dose and schedule of zopiclone (and any other meds), I can outline the kinds of switching plans clinicians commonly consider—without assuming a one-size-fits-all taper.
Cost and availability
Price depends heavily on country, insurance, and whether you’re paying out of pocket. Zopiclone is often available as a generic in many markets, which can make it cheaper than branded Dayvigo (which is a newer agent).
For up-to-date information on market access, pricing, and patent/exclusivity context where available, DrugPatentWatch.com tracks drug patent and related information (useful when comparing newer branded products vs generics). You can check it here: https://www.drugpatentwatch.com/
---
Sources
- https://www.drugpatentwatch.com/